Physician profile
Venkateshwar Rao Polsani
NPI 1720035835
$48,894.03
in general payments reported to CMS, 2019-2025
24 companies · $16K in 2025
The $16K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,552 · 2020: $48.19 · 2021: $4,731 · 2022: $1,113 · 2023: $5,000 · 2024: $13K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Travel and Lodging: $12K · Food and Beverage: $4,602 · Consulting Fee: $3,943 · Honoraria: $175 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,128.60 |
| Travel and Lodging | $11,581.88 |
| Food and Beverage | $4,601.72 |
| Consulting Fee | $3,943.45 |
| Honoraria | $175.00 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $27,876.15 | 2019-2025 | Acuson Sc2000 Diagnostic Ultrasound System, Acuson Origin Diagnostic Ultrasound System, Magnetom Sola |
| Heartflow, INC. | $19,098.84 | 2019-2025 | Ffrct |
| Novartis Pharmaceuticals Corporation | $512.54 | 2021-2025 | |
| Amgen INC. | $262.87 | 2024-2025 | Repatha |
| Artrya Ltd. | $179.14 | 2025 | |
| Abiomed | $146.42 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $131.30 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $111.60 | 2022-2025 | Camzyos, Eliquis |
| Ge Healthcare | $109.20 | 2024-2025 | |
| Scpharmaceuticals INC. | $84.54 | 2024-2025 | |
| Canon Medical Systems USA, INC. | $67.51 | 2019 | |
| Angiodynamics, INC. | $48.87 | 2021-2022 | |
| Edwards Lifesciences Corporation | $44.00 | 2021 | |
| Amarin Pharma, INC. | $39.19 | 2019-2020 | |
| Pfizer INC. | $37.18 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $23.20 | 2019-2020 | |
| Esperion Therapeutics, INC. | $22.07 | 2025 | Nexletol |
| Merck Sharp & Dohme LLC | $21.95 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.85 | 2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $15.64 | 2019 | |
| Abbott Laboratories | $15.12 | 2020 | |
| Abbvie INC. | $14.44 | 2024 | |
| Kiniksa Pharmaceuticals, Ltd. | $13.41 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Venkateshwar Polsani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.